Download the free whitepaper: Unravelling the complexities of genomics-driven drug discovery
Genomics-driven drug discovery holds immense promise in developing targeted therapies by leveraging genetic and biomarker information to understand the root causes of diseases. However, the field faces significant hurdles.
In this whitepaper, we examine the obstacles of limited recontactability, scarcity of multi-omics data sets, lack of diversity in data, and the challenge of scaling research for rare diseases. By addressing these challenges and proposing strategies to address them, this whitepaper aims to chart a path by which we can harness the full potential of genomics-driven drug discovery.
Download report
Overcoming rare disease trial hurdles: Practical strategies for sponsors
Rare disease trials face unique barriers, from small, dispersed populations to high participation burdens and limited historical data. However, many of these challenges can be mitigated through early, transparent, and sustained engagement with patients and families.
In this report, Sano Genetics’ rare disease experts share six proven strategies sponsors can use to design and run more successful trials, from building trust and flexibility into study design to using technology thoughtfully.
Download now to learn how to put patients at the center to enhance participation while reducing unnecessary burden.